Advances and challenges in cancer immunotherapy: mechanisms, clinical applications, and future directions
Cancer is a major threat to public health today, particularly due to the emergence of drug resistance and disease re-emergence post-traditional treatment. Regulatory T cells (Tregs) support cancer progression through their immunosuppressive mechanisms expressing co-inhibitory molecules like programm...
Saved in:
| Main Authors: | Neeharika Vatsavai, Sumeet Kaur Bhinder, Rahaman Shaik, Shaheen Mahira, Shruti Kapoor, Md Shadab Ali, Deepak Verma, Jay Singh, Sreelakshmi Badavenkatappa Gari, Prabhat Upadhyay, Yeva Meshkovska, Chandraiah Godugu, Sowjanya Thatikonda, Venkatesh Pooladanda |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1602529/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A systematic review of gastritis as an immune-related adverse event in clinical interventions
by: Fei Su, et al.
Published: (2024-12-01) -
Prognostic value of the levels of CTLA-4 and its ligand B7.2 in patients with colorectal cancer
by: A. V. Chetveryakov, et al.
Published: (2023-07-01) -
INFLUENCE OF ANTIBODIES AGAINST CTLA-4 AND PD-1 UPON QUANTITIES OF THEIR TARGET RECEPTORS
by: I. O. Chikileva, et al.
Published: (2019-01-01) -
Inosine shapes PD-1 blockade responses and synergizes with dual PD-1/CTLA-4 immunotherapy to enhance antitumor immunity
by: Yoichiro Narikawa, et al.
Published: (2025-08-01) -
Challenges in subtyping disease entities of thyroid dysfunction following combined immune checkpoint inhibitor therapy: a case report
by: Marco Juul Thomsen, et al.
Published: (2025-07-01)